Integrating druggability and genetic variability of coronavirus genomes to inform drug discovery against COVID-19 and future pandemic threats
- Funded by Natural Sciences and Engineering Research Council of Canada (NSERC)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$38,000Funder
Natural Sciences and Engineering Research Council of Canada (NSERC)Principal Investigator
Matthieu SchapiraResearch Location
CanadaLead Research Institution
TorontoResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
Human pharmaceuticals